| Cohort . | Total exomes . | Exomes with deleterious variant . | Fisher’s test . | OR (95% CI) . |
|---|---|---|---|---|
| HGID-CVID | 305 | 7 | 2.78 × 10−15 | 697.9 (133.2–8,192) |
| gnomAD control | 60,146 | 2a | ||
| HGID-CVID EUR | 220 | 5 | 5.73 × 10−11 | ∞ (102.2–∞) |
| gnomAD control NFE | 24,146 | 0 |
| Cohort . | Total exomes . | Exomes with deleterious variant . | Fisher’s test . | OR (95% CI) . |
|---|---|---|---|---|
| HGID-CVID | 305 | 7 | 2.78 × 10−15 | 697.9 (133.2–8,192) |
| gnomAD control | 60,146 | 2a | ||
| HGID-CVID EUR | 220 | 5 | 5.73 × 10−11 | ∞ (102.2–∞) |
| gnomAD control NFE | 24,146 | 0 |
EUR, European; NFE, non-Finnish European.
One variant has been reported in patients with CVID.